Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

NCT01093573 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Untreated Adult Acute Myeloid Leukemia

Interventions

DRUG: midostaurin
DRUG: azacitidine
OTHER: bone marrow aspiration
OTHER: mutation analysis
OTHER: Pharmacokinetic study

Sponsor

Brenda Cooper, MD

Collaborators

[object Object]